ICON Early Phase Services Clinical Trial Study for Healthy and Age 18-64? Compensation up to $9,500 for participation in Research Study #02192600-A​ in Salt Lake City, UT

Study Scavenger Clinical Trial Platform ICON Early Phase Services Clinical Trial Study for Healthy and Age 18-64? Compensation up to $9,500 for participation in Research Study #02192600-A​ in Salt Lake City, UT Volunteers must be available for up to 2 screening...

Kiniksa Highlights Phase 2 Study Data Showing the Corticosteroid-Sparing Effect of Rilonacept in Patients with Recurrent Pericarditis at the American College of Cardiology’s 69th Annual Scientific Session

– Phase 2 study data show the potential for rilonacept treatment to eliminate or reduce the risk of corticosteroid-associated morbidity in recurrent pericarditis – – Enrollment complete for the pivotal Phase 3 trial of rilonacept in recurrent...
SEARCH FOR STUDIES